Dr Michael Feher

Consultant in Diabetes and Clinical Pharmacology

MB BS, MD, FRCP

Specialties Endocrinology and diabetes

Special interests Lipids, Diabetes, New diabetes therapies, Insulin Pump therapy, Hypertension, Obesity, Cardiovascular Risk Factors, Thyroid conditions, Adult Refsums disease

Works At

Get in Touch Here

About

  • Biography icon plus

    Dr Michael Feher is Consultant Physician at Wellington Hospital, and Consultant Physician and Clinical Lead for lipid, diabetes, and hypertension service at Chelsea & Westminster Hospital, London. He is also Visiting Associate Clinical Professor of the Department of Epidemiology & Population Health at the Albert Einstein School of Medicine in NewYork, USA, and Honorary Reader at CSRI Warwick Medical School in Warwick, UK.

    Dr Feher has developed and currently leads several unique specialist services including lipid clinics in adults (joint with chemical pathology) and family lipids (joint with paediatrics), new diabetes therapies, liaison-psychiatry-diabetes, HIV-diabetes, insulin pump and diabetic hypertension. He is currently diabetes assessor to London Metropolitan/Home County Police and London Ambulance Services and diabetes adviser to British National Formulary. National /International committees include: NICE Committees for statins and type 2 diabetes, European Medicine Agency diabetes representative and DVLA panel for diabetes.

    Over the past twenty five years Dr Feher has had extensive clinical experience in the fields of lipids, diabetes, and hypertension. He has made considerable advances in combining clinical pharmacology, pharmaco-epidemiology and laboratory-based research with diabetes clinical care and teaching. He was cofounder of the Diabetes Therapies Evaluation Network (DTEN), which is a research group, established to specifically evaluate phase 4 and early introduction into clinical practice of new therapies specific to diabetes. He has published extensively in the fields of lipids and lipid disorders, diabetes, hypertension, cardiovascular risk factors and clinical pharmacology, with over 150 publications and 8 books in diabetes and cardiovascular medicine.

  • Clinical interests icon plus

    Lipids, Diabetes, New diabetes therapies, Insulin Pump therapy, Hypertension, Obesity, Cardiovascular Risk Factors, Thyroid conditions, Adult Refsums disease

back to top